Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Income from Non-Controlling Interests (2018)

Traws Pharma (TRAW) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with -$163000.0 as the latest value for Q2 2018.

  • On a quarterly basis, Income from Non-Controlling Interests changed N/A to -$163000.0 in Q2 2018 year-over-year; TTM through Dec 2018 was -$163000.0, a N/A change, with the full-year FY2018 number at $163000.0, changed N/A from a year prior.
  • Income from Non-Controlling Interests was -$163000.0 for Q2 2018 at Traws Pharma, down from -$20000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$20000.0 in Q4 2014 to a low of -$163000.0 in Q2 2018.
  • A 3-year average of -$45714.3 and a median of -$27000.0 in 2014 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: plummeted 53.85% in 2014, then surged 35.14% in 2015.
  • Traws Pharma's Income from Non-Controlling Interests stood at -$20000.0 in 2014, then changed by 0.0% to -$20000.0 in 2015, then tumbled by 715.0% to -$163000.0 in 2018.
  • Per Business Quant, the three most recent readings for TRAW's Income from Non-Controlling Interests are -$163000.0 (Q2 2018), -$20000.0 (Q2 2015), and -$24000.0 (Q1 2015).